Friends of IARC

“IARC is to be congratulated for its enduring efforts as an essential agency for global cancer control. Agency staff and collaborators provide not only reliable global cancer data, and information on hot cancer topics through the Monographs, but also great training opportunities for the next generation of cancer experts for developed countries and for developing nations.” 

Professor Ian Frazer is a clinician scientist, trained as a clinical immunologist in Scotland. As a professor at the University of Queensland, he leads a research group working at the Translational Research Institute in Brisbane, Australia, on the immunobiology of epithelial cancers. He is recognized as co-inventor of the technology enabling the human papillomavirus (HPV) vaccines, currently used worldwide to help prevent cervical cancer. Professor Frazer heads a biotechnology company, Admedus Vaccines, working on new vaccine technologies, and is a board member of several companies and not-for-profit organizations. He is the current president of the Australian Academy of Health and Medical Sciences, and a member of the Commonwealth Science Council, and was most recently appointed chair of the federal government′s Medical Research Future Fund. 

Professor Frazer was recognized as Australian of the Year in 2006. He received the Prime Minister′s Prize for Science and the Balzan Prize, both in 2008, and was elected Fellow of the Royal Society of London in 2012. He was appointed Companion of the Order of Australia in the Queen′s Birthday Honours list in 2013.